USA Financial Portformulas »

United Therapeutics Corporation shares owned by USA Financial Portformulas

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by USA Financial Portformulas from 13F filings

Historical chart of USA Financial Portformulas investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by USA Financial Portformulas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by USA Financial Portformulas

Quarter filed Position value Share count Share price at filing
2024-09-30 $33k 91 358.35
2023-09-30 $51k 227 225.87
2023-06-30 $50k 227 220.75
2023-03-31 $55k 244 223.96
2020-06-30 $530k 4.4k 120.89
2015-03-31 $546k 3.2k 172.40

More positions owned by USA Financial Portformulas

iShares MSCI EAFE ETF Msci Eafe Etf (EFA)
SPDR S&P 500 Tr Unit (SPY)
iShares S&P 500 Growth ETF S&p 500 Grwt Etf (IVW)
Invesco QQQ Trust ETF Unit Ser 1 (QQQ)
iShares S&P Mid-Cap 400 Growth ETF S&p Mc 400gr Etf (IJK)
iShares iBoxx USD Inv Grade Corp Bond ETF Iboxx Inv Cp Etf (LQD)
iShares Core S&P 500 Core S&p500 Etf (IVV)
SPDR Series Trust - SPDR Bloomberg Barclays 1-3 Month T-Bill ETF Bloomberg 1-3 Mo (BIL)
iShares iBoxx USD High Yield Corp Bond ETF Iboxx Hi Yd Etf (HYG)
Metropcs Communications (TMUS)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Cintas Corporation (CTAS)
Intuitive Surgical Com New (ISRG)
Costco Wholesale Corporation (COST)

View all positions for USA Financial Portformulas

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation